期刊文献+

质子泵抑制剂对消化道微生态影响的生物学机制 被引量:6

Biological mechanism of proton pump inhibitors on intestinal microecology
原文传递
导出
摘要 近年来,消化道微生态的相关研究引起广大研究者注意。研究表明质子泵抑制剂(proton pump inhibitors,PPIs)可通过对消化道微生物产生影响,继而引起消化道微生态发生改变。本文分析了PPIs引起消化道微生物变化的相关疾病及原因,发现PPIs通过抑制中性粒细胞的杀菌活性来破坏炎症反应。此外,PPIs抑制胃酸分泌,导致消化道细菌移位、细菌过度生长、肠道通透性增加、肠道蠕动改变和肠道微生物群被破坏,致使肠道黏膜屏障受损和继发性肠道功能失调,由此引起消化道微生态失衡。 In recent years, related research on digestive tract microecology has attracted the attention of researchers. Studies have shown that proton pump inhibitors(PPIs) can affect microbes in the digestive tract by influencing the digestive tract microbes. In this paper, we analyzed the related diseases and causes revolving PPIs causing microbial changes in the digestive tract, and found that PPIs impaired the inflammatory process by inhibiting the bactericidal activity of neutrophils. In addition, PPIs inhibit gastric acid secretion, leading to intestinal bacterial translocation, intestinal bacterial overgrowth, increased intestinal permeability, intestinal peristalsis, microbial destruction, damage to the intestinal mucosal barrier,and secondary intestinal function disorder, which causes micro-ecological imbalance in the digestive tract.
作者 冯小雪 燕忠生 FENG Xiao-xue;YAN Zhong-sheng(College of Integrated Chinese and Western Medicine,Gansu University of Chinese Medicine,Lanzhou,Gansu 730000,China;不详)
出处 《中国微生态学杂志》 CAS CSCD 2021年第1期116-119,F0003,共5页 Chinese Journal of Microecology
关键词 质子泵抑制剂 微生态 生物学机制 Proton pump inhibitors Microecology Biological mechanisms
  • 相关文献

参考文献1

二级参考文献11

  • 1Yan-Yan Ma,Lin Li,Chao-Hui Yu,Zhe Shen,Li-Hua Chen,You-Ming Li.Effects of probiotics on nonalcoholic fatty liver disease:A meta-analysis[J].World Journal of Gastroenterology,2013,19(40):6911-6918. 被引量:38
  • 2Maitreyi Raman,Iftikhar Ahmed,Patrick M. Gillevet,Chris S. Probert,Norman M. Ratcliffe,Steve Smith,Rosemary Greenwood,Masoumeh Sikaroodi,Victor Lam,Pam Crotty,Jennifer Bailey,Robert P. Myers,Kevin P. Rioux.Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease[J].Clinical Gastroenterology and Hepatology.2013(7)
  • 3Z. M. Younossi,M. J. Reyes,A. Mishra,R. Mehta,L. Henry.Systematic review with meta‐analysis: non‐alcoholic steatohepatitis ‐ a case for personalised treatment based on pathogenic targets[J].Aliment Pharmacol Ther.2014(1)
  • 4J. P. Ong,Z. M. Younossi.Editorial: probiotics in NASH – more studies are needed[J].Aliment Pharmacol Ther.2014(2)
  • 5A. Alisi,G. Bedogni,G. Baviera,V. Giorgio,E. Porro,C. Paris,P. Giammaria,L. Reali,F. Anania,V. Nobili.Randomised clinical trial: the beneficial effects of VSL #3 in obese children with non‐alcoholic steatohepatitis[J].Aliment Pharmacol Ther.2014(11)
  • 6Vivek Kesar,Joseph A. Odin.Toll‐like receptors and liver disease[J].Liver Int.2014(2)
  • 7Valentina Giorgio,Luca Miele,Luigi Principessa,Francesca Ferretti,Maria Pia Villa,Valentina Negro,Antonio Grieco,Anna Alisi,Valerio Nobili.Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity[J].Digestive and Liver Disease.2014
  • 8Teresa Requena,Paul Cotter,Danit R. Shahar,Charlotte R. Kleiveland,M. Carmen Martínez-Cuesta,Carmen Peláez,Tor Lea.Interactions between gut microbiota, food and the obese host[J].Trends in Food Science & Technology.2013(1)
  • 9Luca Miele,Giuseppe Marrone,Cristiano Lauritano,Consuelo Cefalo,Antonio Gasbarrini,Chris Day,Antonio Grieco.Gut-liver Axis and Microbiota in NAFLD: Insight Pathophysiology for Novel Therapeutic Target[J].Current Pharmaceutical Design.2013(29)
  • 10Ding-You Li,Min Yang,Sarah Edwards,Shui-Qing Ye.Nonalcoholic Fatty Liver Disease[J].Journal of Parenteral and Enteral Nutrition.2013(6)

共引文献56

同被引文献74

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部